Neuraxis (NRXS) EBITDA Margin (2022 - 2025)
Neuraxis (NRXS) recorded EBITDA Margin of -174.85% in Q4 2025, up 16.92 percentage points from -191.78% a year earlier and up 81.97 percentage points from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) EBITDA Margin (2022 - 2025) Analysis & Trends
For FY2025, Neuraxis reported EBITDA Margin of -217.70%, up 47.35 percentage points from FY2024.
- Annual EBITDA Margin has a three-year change of -93.48 percentage points (FY2022 to FY2025).
- Across earlier years, EBITDA Margin came in at -265.05% in FY2024 (+4.21 pp), -269.25% in FY2023 (-145.03 pp) and -124.22% in FY2022.
- The Q4 2025 figure is the highest quarterly EBITDA Margin since Q2 2023.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +42.24 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 384.55 percentage points in Q3 2024, against a drop of 437.78 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -256.82% (Q3 2025), -190.69% (Q2 2025) and -255.54% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.17 Bn | 228.32 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 179.42 Bn | 150.51 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 161.98 Bn | 145.80 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 156.76 Bn | 137.18 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 122.13 Bn | 88.00 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.84 Bn | 103.96 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 66.19 Bn | 61.20 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 54.16 Bn | 51.31 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.35 Bn | 35.47 Bn | 1.35 Bn | 31.93% |
| 10 | Neuraxis | 92.39 Mn | 67.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -174.85% |
| Sep 30, 2025 | -256.82% |
| Jun 30, 2025 | -190.69% |
| Mar 31, 2025 | -255.54% |
| Dec 31, 2024 | -191.78% |
| Sep 30, 2024 | -240.18% |
| Jun 30, 2024 | -348.66% |
| Mar 31, 2024 | -278.32% |
| Dec 31, 2023 | -303.46% |
| Sep 30, 2023 | -352.09% |
| Jun 30, 2023 | -33.96% |
| Mar 31, 2023 | 220.62% |
| Dec 31, 2022 | -147.48% |
| Sep 30, 2022 | -190.49% |
| Jun 30, 2022 | -95.05% |
API Access
Neuraxis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();